Harpoon Therapeutics Inc. (HARP)
NASDAQ: HARP
· Real-Time Price · USD
23.01
0.02 (0.09%)
At close: Mar 08, 2024, 10:00 PM
Harpoon Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -30.5M | -40.34M | -58.75M | -67.73M | -70.86M | -75.91M | -75.32M | -116.72M | -106.53M | -103.15M | -99.08M |
Depreciation & Amortization | 1.95M | 2.24M | 2.42M | 2.36M | 2.24M | 2.24M | 2.25M | 2.19M | 2.17M | 2.17M | 2.13M |
Stock-Based Compensation | 4.61M | 5.47M | 6.93M | 8.64M | 9.79M | 10.35M | 10.17M | 9.46M | 8.14M | 7.31M | 6.15M |
Other Working Capital | -43.36M | -50.89M | -35.35M | -35.63M | -30.9M | -23.56M | -69.52M | -20.45M | -26.35M | -21.77M | 79.33M |
Other Non-Cash Items | -5.25M | 3.92M | 1.13M | 1.13M | 1.07M | 1.07M | 896K | 456K | 424K | 390K | 359K |
Deferred Income Tax | 2.07M | 2.25M | n/a | n/a | 515K | 1.2M | 1.79M | 2.37M | 2.09M | 1.53M | 1M |
Change in Working Capital | -42.27M | -50.34M | -34.96M | -33.58M | -30.38M | -23.32M | -69.1M | -19.91M | -26.79M | -21.54M | 80.26M |
Operating Cash Flow | -69.38M | -76.8M | -83.23M | -89.18M | -87.63M | -84.35M | -129.31M | -122.15M | -120.49M | -113.3M | -9.18M |
Capital Expenditures | -119K | -294K | -347K | 250K | 223K | 489K | 542K | -100K | -103K | -573K | -723K |
Cash Acquisitions | 1.28M | 1.28M | 938K | -597K | -597K | -597K | -597K | n/a | n/a | n/a | n/a |
Purchase of Investments | -27.16M | -37.14M | -25.43M | -35.94M | -41.82M | -63.01M | -79.51M | -151.97M | -194.66M | -196.08M | -238.63M |
Sales Maturities Of Investments | 17.77M | 34.61M | 75.64M | 114.51M | 136.37M | 137.52M | 183.69M | 186.42M | 220.88M | 237.22M | 171.15M |
Other Investing Acitivies | 11.51M | 11.51M | 10.91M | 11.51M | n/a | n/a | 597K | n/a | n/a | n/a | n/a |
Investing Cash Flow | 3.28M | 9.96M | 61.72M | 89.74M | 94.18M | 74.4M | 104.71M | 34.35M | 26.11M | 40.57M | -68.21M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 748.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 33M | 31.07M | 32.16M | 6.37M | 1.03M | 1.31M | 4.21M | 111.52M | 114.72M | 115.41M | 112.55M |
Financial Cash Flow | 33M | 31.07M | 32.16M | 6.37M | 1.03M | 1.31M | 4.21M | 111.52M | 114.72M | 115.41M | 112.55M |
Net Cash Flow | -33.1M | -35.77M | 10.65M | 6.93M | 7.58M | -8.64M | -20.39M | 23.72M | 20.34M | 42.67M | 35.17M |
Free Cash Flow | -69.5M | -77.1M | -83.58M | -88.93M | -87.4M | -83.86M | -128.77M | -122.25M | -120.59M | -113.87M | -9.9M |